#USA #Tampa #TPA #PBM #Marpai Inc.

Marpai Inc. Sees Significant Growth

Marpai, Inc., a frontrunner in healthcare technology and services, has announced an impressive expansion that is expected to reshape its business landscape. With an addition of 192,000 new estimated member lives expected between August 2026 and January 2027, the company is poised for substantial growth driven by its Third-Party Administration (TPA) and MarpaiRx Pharmacy Benefit Management (PBM) platforms.

This surge in member lives signifies nearly a six-fold increase from current levels, a pivotal transformation that could significantly enhance Marpai's financial positioning. The company anticipates achieving positive cash flow and EBITDA beginning in August 2026 as a result of this growth.

Unprecedented Growth Strategy

The announcement comes after securing a series of new business commitments and heightened demand in the healthcare sector for Marpai's innovative and transparent technology solutions. Marpai projects that two major clients alone will contribute approximately 35,000 new member lives when they go live on August 1, 2026. Moreover, the company is targeting regional municipal engagements, with a notable 2,500-life group starting on July 1, which reflect a robust pipeline for high-volume opportunities in states such as Wisconsin, New Jersey, and Texas.

Simultaneously, in the PBM sector, Marpai has committed to onboarding 50,000 new lives, set to launch between September 1, 2026, and January 1, 2027. This introduction is expected to capitalize on MarpaiRx’s unique offerings, particularly its specialized rebate aggregation services designed for better cost efficiency.

Management Perspective

Damien Lamendola, Marpai’s CEO, characterized this growth phase as a critical turning point, stating, "Securing 192,000 estimated new member lives validates the power of our integrated TPA and MarpaiRx PBM models. Employers are increasingly demanding transparency and sustainable savings, which our platform successfully delivers." He emphasized that this extraordinary growth not only confirms Marpai’s operational capabilities but also significantly advances its financial outlook.

The projected growth signals a robust and strategic adjustment in Marpai's financial strategy. Achieving positive cash flow and EBITDA marks a decisive inflection point for the firm, establishing a solid foundation for future initiatives.

A Glimpse into Marpai’s Future

Marpai operates as a technology platform company, specializing in TPA and PBM services that deliver value-oriented health plan options. By focusing on improving the health of its member population through programs like Marpai Saves, the company enhances its competitive edge and strengthens its market presence. In partnership with leading provider networks such as Aetna and Cigna, Marpai aims to expand its influence nationwide.

As Marpai sets forth on this ambitious journey, it encourages investors to stay informed by visiting their investor relations webpage for detailed updates and insights on future developments. The future appears bright for Marpai, a company firmly committed to reshaping the healthcare technology landscape through innovation and growth.

For further information, please visit Marpai Inc.. Investors are also invited to explore ongoing updates about the firm’s progress in their financial filings with the Securities and Exchange Commission (SEC).